Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)

Basaglar was well tolerated with few hypoglycemic events and significantly reduced HbA1c and BG from baseline in Indian insulin-naïve patients with T2DM.

Authors

Keyur Brahme
Paramesh Shamanna
Erik Spaepen (ORCID: https://orcid.org/0000-0001-7590-7844)
Parag Shah (ORCID: https://orcid.org/0000-0002-8016-4077)
Piyush Desai
Indranil Bhattacharya (ORCID: https://orcid.org/0000-0002-6074-6272)
Rohit Arora (ORCID: https://orcid.org/0000-0002-4843-7303)
Banshi Saboo
Deepak Khandelwal

Institutions

Nirma (India) (IN)

Publication Details

Journal: Journal of the Association of Physicians of India
Published: 2025-02-01
DOI: https://doi.org/10.59556/japi.73.0842
Primary Topic: Diabetes Management and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)

Keyur Brahme, Paramesh Shamanna, Erik Spaepen, Parag Shah et al.

Feb 1, 2025

Journal of the Association of Physicians of India

Diabetes Management and Research

article

Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX)

Keyur Brahme, Paramesh Shamanna, Erik Spaepen, Parag Shah, Piyush Desai, Indranil Bhattacharya, Rohit Arora, Banshi Saboo, Deepak Khandelwal

February 1, 2025article en

Abstract

Basaglar was well tolerated with few hypoglycemic events and significantly reduced HbA1c and BG from baseline in Indian insulin-naïve patients with T2DM.

Journal of the Association of Physicians of IndiaVol. 73(2)

Nirma (India) (IN)

Good health and well-being

Openalex Percentile: Top 97%

Diabetes Management and Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety and Efficacy of Biosimilar Insulin Glargine (Basaglar) in Indian Patients with Type 2 Diabetes Mellitus: Results from a Multicenter, Open-Label, Single-Arm, Phase 4 Trial (ABEX) — Keyur Brahme, Paramesh Shamanna, et al. · Journal of the Association of Physicians of India (2025) | TGRS Research Map | TGRS